Cryo-Cell International Overview
- Founded
-
1989
- Status
-
Public
- Employees
-
88
- Stock Symbol
-
CCEL
- Investments
-
4
- Share Price
-
$4.50
- (As of Tuesday Closing)
Cryo-Cell International General Information
Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Contact Information
Primary Industry
Other Healthcare Services
Stock Exchange
ASE
Primary Office
- 700 Brooker Creek Boulevard
- Suite 1800
- Oldsmar, FL 34677
- United States
+1 (813) 000-0000
Cryo-Cell International Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.50 | $4.52 | $2.69 - $8.12 | $37.5M | 8.3M | 10.5K | $0.33 |
Cryo-Cell International Financials Summary
|
In Thousands, USD |
TTM 28-Feb-2023 | FY 2022 30-Nov-2022 | FY 2021 30-Nov-2021 | FY 2020 30-Nov-2020 |
|---|---|---|---|---|
| EV | 42,146 | 43,720 | 101,483 | 55,486 |
| Revenue | 30,903 | 30,337 | 28,885 | 31,148 |
| EBITDA | 6,846 | 6,650 | 5,317 | 7,219 |
| Net Income | 2,706 | 2,771 | 2,084 | 3,625 |
| Total Assets | 66,134 | 64,888 | 60,662 | 46,200 |
| Total Debt | 11,010 | 11,614 | 2,821 | 6,240 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Cryo-Cell International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cryo-Cell International Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three
Other Healthcare Services
Oldsmar, FL
88
As of 2022
00000
000000&0
000000
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nost
00000 0000000000 000
New York, NY
00
As of 0000
00000
000000000 -
00000
000000
a commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit e
00000 0000000000 000
Chennai, India
0000
As of 0000
000.00
00.00
0000-00-00
00000000000
000.00
Add Comparison
Cryo-Cell International Competitors (5)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Americord | Accelerator/Incubator Backed | New York, NY | 00 | 00000 | 000000000 - | 00000 |
| 00000000 000000000 | Venture Capital-Backed | Chennai, India | 0000 | 000.00 | 00000000000 | 000.00 |
| 00000000000 | Formerly VC-backed | Florham Park, NJ | 00 | 00000 | 000000&0 | |
| 0000 00000 0000000 | Formerly PE-Backed | Los Angeles, CA | 000 | 00000 | 000000000000 | |
| 00000000 | Venture Capital-Backed | Baldwin Park, CA | 000 | 000.00 | 00000000000 | 000.00 |
Cryo-Cell International Patents
Cryo-Cell International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2795248-A1 | Cell therapy to improve wound healing and related compositions and methods | Inactive | 01-Apr-2010 | 000000000 | |
| EP-2553089-A1 | Cell therapy to improve wound healing and related compositions and methods | Inactive | 01-Apr-2010 | 000000000 | |
| EP-2553089-A4 | Cell therapy to improve wound healing and related compositions and methods | Inactive | 01-Apr-2010 | 000000000 | 0 |
| AU-2008319284-A1 | Methods for co-culturing cord blood derived cells with menstrual stem cells | Inactive | 31-Oct-2007 | 0000000000 | |
| CA-2714777-A1 | Methods for co-culturing cord blood derived cells with menstrual stem cells | Inactive | 31-Oct-2007 | C12N5/0647 |
Cryo-Cell International Executive Team (8)
Cryo-Cell International Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 0000000 | Cryo-Cell International | Board Member | 000 0000 |
| 00000 0000000 | Cryo-Cell International | Chairman & Chief Executive Officer | 000 0000 |
| 000000 000000 | Cryo-Cell International | Board Member | 000 0000 |
| 0000 0000000 | Cryo-Cell International | Chief Executive Officer & Board Member | 000 0000 |
Cryo-Cell International Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cryo-Cell International Investments & Acquisitions (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000:000 0000 | 11-Jun-2018 | 0000000000 | 0000 | Other Healthcare Services | 00000 000 |
| 00000000000 0 | 30-Jun-2015 | 0000000000 | 00.00 | Biotechnology | 00000 000 |
| 0000 00000 00 | 10-Mar-2015 | 0000 | Biotechnology | 00000 000 | |
| S-Evans Biosciences | 12-Aug-2009 | Merger/Acquisition | Biotechnology |
Cryo-Cell International Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| S-Evans Biosciences | Biotechnology | Hangzhou, China | 2009 |
| 0000:000 0000 0000 | Other Healthcare Services | Orlando, FL | 0000 |
Cryo-Cell International Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000 00000 0000000 | 10-Mar-2015 | 0000 | Completed |
|